Breast and Cervical Cancer Early Detection and Control Advisory Committee (BCCEDCAC), 8700 [E8-2795]

Download as PDF 8700 Federal Register / Vol. 73, No. 31 / Thursday, February 14, 2008 / Notices Dated: February 6, 2008. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention (CDC). [FR Doc. E8–2796 Filed 2–13–08; 8:45 am] Dated: February 6, 2008. Elaine L. Baker, Director, Management Analysis and Service Office, Centers for Disease Control and Prevention (CDC). [FR Doc. E8–2795 Filed 2–13–08; 8:45 am] BILLING CODE 4163–18–P BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Centers for Disease Control and Prevention Breast and Cervical Cancer Early Detection and Control Advisory Committee (BCCEDCAC) Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Monitoring and Evaluation of Malaria Activities in the Greater Mekong Sub-Region, Request for Applications (RFA) CK08–003 rwilkins on PROD1PC63 with NOTICES In accordance with section 10(a)(2)of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the following meeting of the aforementioned committee: Times and Dates: 8:30 a.m.–5p.m., March 4, 2008. 8:30 a.m.–1p.m., March 5, 2008. Place: Centers for Disease Control and Prevention, 1600 Clifton Road, NE., Tom Harkin Global Community Center, Building 19, Atlanta, Georgia 30333, Telephone: (404) 639–1717. Status: Open to the public, limited only by the space available. Purpose: The committee is charged with advising the Secretary, Department of Health and Human Services, and the Director, CDC, regarding the early detection and control of breast and cervical cancer. The committee makes recommendations regarding national program goals and objectives; implementation strategies; and program priorities including surveillance, epidemiologic investigations, education and training, information dissemination, professional interactions and collaborations, and policy. Matters To Be Discussed: The agenda will include a review and discussion of the National Breast and Cervical Cancer Early Detection Program components; and related policies and emerging issues. Agenda items are subject to change as priorities dictate. Contact Person for More Information: Debra Younginer, Executive Secretary, BCCEDCAC, Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion, CDC, 4770 Buford Highway, Mailstop K–57, Chamblee, Georgia 30316, Telephone: (770) 488–1074. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities for both CDC and the Agency for Toxic Substances and Disease Registry. VerDate Aug<31>2005 16:49 Feb 13, 2008 Jkt 214001 In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting. Time and Date: 12 p.m.–2 p.m., March 13, 2008 (Closed). Place: Teleconference. Status: The meeting will be closed to the public in accordance with provisions set forth in section 552b(c) (4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92– 463. Matters To Be Discussed: The meeting will include the review, discussion, and evaluation of ‘‘Monitoring and Evaluation of Malaria Activities in the Greater Mekong Sub-Region, RFA CK08–003.’’ Contact Person For More Information: Christine Morrison, PhD, Scientific Review Administrator, CDC, 1600 Clifton Road, NE., Mailstop D72, Atlanta, GA 30333, Telephone: (404) 639–3098. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. Dated: February 7, 2008. Elaine L. Baker Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E8–2793 Filed 2–13–08; 8:45 am] BILLING CODE 4163–18–P PO 00000 Frm 00059 Fmt 4703 Sfmt 4703 DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Natural History and Prevention of Viral Hepatitis Among Alaska Natives, Request for Applications (RFA) PS08–004 In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting. Time and Date: 12 p.m.–4 p.m., March 24, 2008 (Closed). Place: Teleconference. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c) (4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. Matters To Be Discussed: The meeting will include the review, discussion, and evaluation of ‘‘Natural History and Prevention of Viral Hepatitis Among Alaska Natives, RFA PS08–004.’’ Contact Person for More Information: Shree Marshall Williams, PhD, M.Sc., Scientific Review Administrator, CDC, 1600 Clifton Road, NE., Mailstop D72, Atlanta, GA 30333, Telephone: (404) 639–4896. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. Dated: February 8, 2008. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E8–2799 Filed 2–13–08; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Office of the Director, Office of Strategy and Innovation, Office of Minority Health and Health Disparities In accordance with Presidential Executive Order No. 13175, November 6, 2000, and the Presidential Memorandum of September 23, 2004, Consultation and Coordination with Indian Tribal Governments, the CDC announces the following meeting: Name: Tribal Consultation Advisory Committee (TCAC) Meeting, An E:\FR\FM\14FEN1.SGM 14FEN1

Agencies

[Federal Register Volume 73, Number 31 (Thursday, February 14, 2008)]
[Notices]
[Page 8700]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-2795]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Breast and Cervical Cancer Early Detection and Control Advisory 
Committee (BCCEDCAC)

    In accordance with section 10(a)(2)of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following meeting of the aforementioned 
committee:

    Times and Dates: 8:30 a.m.-5p.m., March 4, 2008. 8:30 a.m.-
1p.m., March 5, 2008.
    Place: Centers for Disease Control and Prevention, 1600 Clifton 
Road, NE., Tom Harkin Global Community Center, Building 19, Atlanta, 
Georgia 30333, Telephone: (404) 639-1717.
    Status: Open to the public, limited only by the space available.
    Purpose: The committee is charged with advising the Secretary, 
Department of Health and Human Services, and the Director, CDC, 
regarding the early detection and control of breast and cervical 
cancer. The committee makes recommendations regarding national 
program goals and objectives; implementation strategies; and program 
priorities including surveillance, epidemiologic investigations, 
education and training, information dissemination, professional 
interactions and collaborations, and policy.
    Matters To Be Discussed: The agenda will include a review and 
discussion of the National Breast and Cervical Cancer Early 
Detection Program components; and related policies and emerging 
issues.
    Agenda items are subject to change as priorities dictate.
    Contact Person for More Information: Debra Younginer, Executive 
Secretary, BCCEDCAC, Division of Cancer Prevention and Control, 
National Center for Chronic Disease Prevention and Health Promotion, 
CDC, 4770 Buford Highway, Mailstop K-57, Chamblee, Georgia 30316, 
Telephone: (770) 488-1074.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities for both CDC and the Agency for Toxic Substances and 
Disease Registry.

    Dated: February 6, 2008.
Elaine L. Baker,
Director, Management Analysis and Service Office, Centers for Disease 
Control and Prevention (CDC).
[FR Doc. E8-2795 Filed 2-13-08; 8:45 am]
BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.